Literature DB >> 8147355

Helicobacter pylori reinfection rate, in patients with cured duodenal ulcer.

T J Borody1, P Andrews, N Mancuso, D McCauley, E Jankiewicz, N Ferch, N P Shortis, S Brandl.   

Abstract

OBJECTIVE: To determine the reinfection rate of the gastric mucosa in patients previously cured of duodenal ulcers, following the eradication of Helicobacter pylori. Only those remaining H. pylori-negative beyond 12 months of follow-up were studied, to minimize the potential inclusion of patients with H. pylori recrudescence.
METHODS: Patients with endoscopically proven duodenal ulcers who had been treated with triple therapy, resulting in documented eradication of H. pylori and cure of the ulcer for at least 4 years, were recalled and had their H. pylori status determined by the 14C-urea breath test. Those found positive for H. pylori underwent endoscopic confirmation of the infection.
RESULTS: Of the 94 patients restudied, with a follow-up period range of 48-96 months or a total of 549.8 yr, only two (2.2%) were again H. pylori positive. This gives an effective reinfection rate of 0.36% per patient year. In the two H. pylori-positive patients, one had normal mucosa endoscopically, whereas duodenitis without active ulceration was present in the other. The former was asymptomatic, whereas the latter patient was using ranitidine daily for symptom control.
CONCLUSION: In the Australian setting, following cure of duodenal ulcer disease by eradication of H. pylori, subsequent reinfection is an unusual phenomenon. We conclude that efforts aimed at eradication of H. pylori in duodenal ulcer are justified and are worthwhile.

Entities:  

Mesh:

Year:  1994        PMID: 8147355

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

Review 1.  Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes.

Authors:  H X Xia; N J Talley; C T Keane; C A O'Morain
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

2.  High seroprevalence of IgG against Helicobacter pylori among endoscopists in Taiwan.

Authors:  Y C Su; W M Wang; L T Chen; W Chiang; C Y Chen; S N Lu; C M Jan
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

3.  Cost effectiveness of Helicobacter pylori eradication therapies in patients with duodenal ulcer. An analysis of triple therapy versus two dual therapy alternatives.

Authors:  G R Tennvall; A Norinder; B Ohlin
Journal:  Pharmacoeconomics       Date:  1999-09       Impact factor: 4.981

4.  Epidemiology of Helicobacter pylori in Australia: a scoping review.

Authors:  Jillian Congedi; Craig Williams; Katherine L Baldock
Journal:  PeerJ       Date:  2022-05-31       Impact factor: 3.061

Review 5.  A rational approach to uninvestigated dyspepsia in primary care: review of the literature.

Authors:  N L A Arents; J C Thijs; J H Kleibeuker
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

6.  Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.

Authors:  T J Borody; P Andrews; G Fracchia; S Brandl; N P Shortis; H Bae
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

7.  Six-year follow-up after Helicobacter pylori eradication in peptic ulcer disease.

Authors:  H J O'Connor; C Stewart; R Walsh; C N McGee; B Flynn
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089

8.  Reinfection after successful eradication of Helicobacter pylori in three different populations in Alaska.

Authors:  M G Bruce; D L Bruden; J M Morris; A L Reasonover; F Sacco; D Hurlburt; T W Hennessy; J Gove; A Parkinson; G Sahagun; P Davis; J Klejka; B J McMahon
Journal:  Epidemiol Infect       Date:  2014-07-28       Impact factor: 4.434

9.  Helicobacter pylori in dental plaque and saliva.

Authors:  N Kim; S H Lim; K H Lee; J Y You; J M Kim; N R Lee; H C Jung; I S Song; C Y Kim
Journal:  Korean J Intern Med       Date:  2000-12       Impact factor: 2.884

10.  Long-term follow-up of Helicobacter pylori reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study.

Authors:  Yong Xie; Conghua Song; Hong Cheng; Canxia Xu; Zhenyu Zhang; Jiangbin Wang; Lijuan Huo; Qin Du; Jianming Xu; Ye Chen; Xiaomei Zhang; Guoxin Zhang; Guibin Yang; Xiuli Zuo; Tao Guo; Yapi Lu; Fen Wang; Xuehong Wang; Kun Zhuang; Shiyao Chen; Wenzhong Liu; Nonghua Lu
Journal:  Emerg Microbes Infect       Date:  2020-03-11       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.